Harbinger Research Issues Investment Report for Telzuit Medical Technologies, Inc.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Harbinger har·bin·ger n. One that indicates or foreshadows what is to come; a forerunner. tr.v. har·bin·gered, har·bin·ger·ing, har·bin·gers To signal the approach of; presage. Research, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , www.harbingerresearch.com, an independent research firm, issued an Investment Report yesterday for Telzuit Medical Technologies, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : TZMT), a developer of ambulatory medical devices which monitor, measure, and record physiological signals generated by the body. The report provides a description of Telzuit's business, industry, products, strategy, management team, and investment opportunities and risks. The report is available free of charge at http://www.harbingerresearch.com. About Harbinger Research, LLC: Harbinger Research is a quality-leading New York based independent equity research company that provides insightful, in-depth equity research coverage and informational reports to smaller U.S. traded companies and the individuals and institutions that invest in them. For further information on Harbinger Research, please visit www.harbingerresearch.com About Telzuit Medical Technologies, Inc. Telzuit Medical Technologies, Inc. (OTCBB: TZMT) is a company focused on researching, developing and marketing ambulatory medical devices which monitor, measure and record physiological signals generated by the body. The company's initial product is the Bio-Patch Wireless Holter Monitor Hol·ter monitor n. A portable device used to measure the electrical activity of the heart over an extended period of time, allowing detection of intermittent arrhythmias and other electrical disturbances. , a patented and FDA-approved disposable bandage-like strip which allows patients to proceed with normal activities while their biometric data is collected and transmitted to a monitoring center on a near real-time, 24-hour basis for analysis. Utilizing an algorithm licensed from Philips Medical (NYSE-PHG), the Bio-Patch is capable of deriving a full 12-lead electrocardiogram electrocardiogram /elec·tro·car·dio·gram/ (-kahr´de-o-gram?) a graphic tracing of the variations in electrical potential caused by the excitation of the heart muscle and detected at the body surface. (ECG ECG electrocardiogram. ECG abbr. 1. electrocardiogram 2. electrocardiograph ECG Also called an electrocardiogram, it records the electrical activity of the heart. ) from a 6-lead vectorcardiographic configuration, also known as the EASI EASI Equal Access to Software and Information EASI Environmental Alliance for Senior Involvement EASI Energy Automation Systems, Inc. EASI Easy Access for Students and Institutions (student financial assistance) EASI Engineered Air Systems Inc. placement. This lead configuration is ideal for ambulatory cardiac monitoring because it provides true vectorcardiographic data with leads that are comfortable to wear and has a minimal impact on limb movement. Additionally, data gathered from a full 12-lead ECG configuration may help clinicians detect the origin of arrhythmias with a higher degree of accuracy. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and : With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to the ability of the Company to increase revenues in the future due to the developing and unpredictable markets for its products, the ability to achieve a positive cash flow, the ability to obtain orders for or install its products, the ability to obtain new customers and the ability to continue to commercialize its products, which could cause actual results or revenues to differ materially from those contemplated by these statements. Harbinger Research, LLC received US$6,500 from the Company in return for report authoring and distribution services. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion